# Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry

Study · id `cardio:ct-nct03048825` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03048825](<https://clinicaltrials.gov/study/NCT03048825>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03048825

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 7264 participants.

## Technical summary

Registry record NCT03048825. Randomized; quadruple masking; primary purpose treatment. Start 2018-02-01 (actual); primary completion 2024-08-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 7264 participants (enrolled count; ClinicalTrials.gov record NCT03048825, source copy `cardio:ctgov-nct03048825-2024-10-15`, retrieved 2026-10-26)
- Started: 2018-02-01 (actual) (ClinicalTrials.gov record NCT03048825, source copy `cardio:ctgov-nct03048825-2024-10-15`, retrieved 2026-10-26)
- Primary completion: 2024-08-09 (actual) (ClinicalTrials.gov record NCT03048825, source copy `cardio:ctgov-nct03048825-2024-10-15`, retrieved 2026-10-26)
- Completion: 2024-08-09 (actual) (ClinicalTrials.gov record NCT03048825, source copy `cardio:ctgov-nct03048825-2024-10-15`, retrieved 2026-10-26)
- Countries: United States; Australia; Canada; Czechia; Egypt; France; Hungary; Nepal; Netherlands; North Macedonia; Serbia; Spain; Switzerland; United Kingdom (ClinicalTrials.gov record NCT03048825, source copy `cardio:ctgov-nct03048825-2024-10-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03048825-2024-10-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry
- Acronym: CLEAR SYNERGY
- Condition: ST Elevation Myocardial Infarction
- Condition: Non ST Elevation Myocardial Infarction
- Intervention (Drug): Colchicine
- Intervention (Drug): Spironolactone
- Intervention (Device): SYNERGY Bioabsorbable Polymer Drug-Eluting Stent
- Intervention (Drug): Colchicine-Placebo
- Intervention (Drug): Spironolactone-Placebo
- Lead sponsor: Population Health Research Institute
- Lead sponsor class: OTHER
- Collaborator: Boston Scientific Corporation
- Collaborator class: INDUSTRY
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry intervention name matches this record: Colchicine (`cardio:colchicine`)
- Registry lists this organization as the lead sponsor: Population Health Research Institute (`cardio:org-population-health-research-institute`)
- Registry lists this organization as a collaborator: Boston Scientific (`cardio:boston-scientific`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Routine Spironolactone in Acute Myocardial Infarction (`cardio:pubmed-39555814`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Colchicine in Acute Myocardial Infarction (`cardio:pubmed-39555823`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 188f38b0b74460b5377207837421b2b1537202f128164d2bb25d082c4781dee7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
